I Almost Transitioned - Here’s Why I Didn’t - Sascha Bailey (#26)
4 August 2025
With Sascha Bailey
UK
Sascha Bailey nearly transitioned at 28 after receiving a gender dysphoria diagnosis in ten minutes and being prescribed hormones on the spot — in Japan, not in the UK, but the clinical failure he describes mirrors precisely what the Cass Review spent four years documenting. A childhood abuse survivor, Bailey reframes his three gender episodes as bids for control during crisis. His perspective on male detransition, trauma, and the algorithmic amplification of identity shifts adds a dimension that the published evidence base in this country has barely begun to address.
The episode features Sascha Bailey, a UK-based tech entrepreneur and author who came close to transitioning at the age of 28 while living in Japan. What makes his account clinically significant is the speed of that near-diagnosis: assessed for gender dysphoria in roughly ten minutes and offered hormone replacement therapy immediately. That description maps onto concerns the Cass Review raised throughout its four-year inquiry — the failure to explore co-occurring conditions, trauma histories, and mental health presentations before placing a patient on a medical pathway. Bailey is candid about the vulnerabilities that preceded his three separate periods of gender questioning. He is a survivor of childhood sexual abuse, and he frames each episode as a response to an absence of control — an attempt to resolve profound distress when other routes felt closed off. PTSD, dissociation, and autistic traits all feature in his account. The Cass Review's final report was explicit that many young people referred to gender services carried significant mental health histories that received inadequate exploration before treatment began; Bailey's experience as an adult reflects a version of the same clinical failure operating in a different jurisdiction and cultural setting. The episode also examines what Bailey describes as the transmaxing movement — online communities where transition is promoted instrumentally, as a career advantage or a form of optimisation rather than as a response to clinical distress. He argues that technology platforms and algorithmic environments can accelerate and entrench identity shifts, creating feedback loops that make stepping back progressively harder. UK researchers and the Cass Review both flagged the role of online communities and social influence in shaping gender dysphoria presentations, particularly among adolescents, and Bailey's description of these dynamics from inside tech culture gives that concern a specific, documented texture. Bailey brings a broader sociological argument about male identity and social role collapse. He contends that as traditional male roles have been stripped away without meaningful replacement, some men — particularly those who are sensitive, introverted, or autistic — are left without a stable framework for selfhood. His book draws on ecological research into overcrowded animal populations to propose that identity crises in affluent societies follow predictable patterns when social structure disintegrates. Whether or not one accepts the analogy, the underlying question — what happens to vulnerable young men when legible social roles disappear — is one that NHS clinicians working in gender services have also started to articulate. From a UK policy standpoint, male detransition remains a data gap. The Cass Review acknowledged that follow-up data on those who stepped back from transition was sparse, and NHS England's new service specifications for under-18s do not yet define how detransitioners' experiences should inform clinical learning. Bailey's account, connecting near-transition directly to trauma and control rather than to innate gender identity, is the kind of first-person evidence that rarely surfaces in peer-reviewed literature but that shapes the clinical picture nonetheless. His expectation of a child, and his description of what he believes sensitive boys actually need, closes the episode on a note the podcast consistently returns to: that good outcomes are possible, and that they tend not to require irreversible medical intervention.
